CVE-2012-3442

Description

The (1) django.http.HttpResponseRedirect and (2) django.http.HttpResponsePermanentRedirect classes in Django before 1.3.2 and 1.4.x before 1.4.1 do not validate the scheme of a redirect target, which might allow remote attackers to conduct cross-site scripting (XSS) attacks via a data: URL.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.44%
Vendor Advisory mandriva.com Vendor Advisory ubuntu.com Vendor Advisory debian.org Vendor Advisory djangoproject.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.openwall.com/lists/oss-security/2012/07/31/1 mailing list
https://www.djangoproject.com/weblog/2012/jul/30/security-releases-issued/ patch vendor advisory
http://www.mandriva.com/security/advisories?name=MDVSA-2012:143 vendor advisory
http://www.ubuntu.com/usn/USN-1560-1 vendor advisory
http://www.openwall.com/lists/oss-security/2012/07/31/2 mailing list
http://www.debian.org/security/2012/dsa-2529 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2012-3442?
CVE-2012-3442 has been scored as a medium severity vulnerability.
How to fix CVE-2012-3442?
To fix CVE-2012-3442, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-3442 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-3442 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.